Vertex Pharmaceuticals (VRTX) NewsBite - One of Today's Top Gainers So Far

Posted: Wednesday, September 24, 2008 3:25 PM EDT
By: Market Intelligence Center Staff





Vertex Pharmaceuticals (VRTX) leads the list of top gainers so far today and is now at $32.00, up $4.70 (17.22%) on volume of 5,377,644 shares traded. Over the last 52 weeks the stock has ranged from a low of $13.84 to a high of $39.48. Vertex Pharmaceuticals stock has been showing support around $26.13 and resistance in the $28.73 range. Technical indicators for the stock are bullish and S&P gives VRTX a positive 4 STARS (out of 5) buy ranking. If you are looking for a hedged play on VRTX the stock seems like it could be a candidate for a November out-of-the-money bull-put credit spread below the 25 range. [ABR-Seven Summits Strategic Investments NewsBite]



CLICK HERE: FREE Vertex Pharmaceuticals (VRTX) Stock Report
See what our analysts have uncovered about Vertex Pharmaceuticals (VRTX).
More News For Vertex Pharmaceuticals (VRTX):

Potential Vertex Pharmaceuticals (VRTX) Trade Has $32.84 Breakeven

Friday, February 10, 2012... Vertex Pharmaceuticals Inc (NASDAQ: VRTX) closed Thursday's trading session at $37.04. In the past year, the stock has hit a 52-week low of $26.50......

http://www.marketintelligencecenter.com/analyfav/1333824

Potential Vertex Pharmaceuticals (VRTX) Trade Targets 34.55% Return

Monday, February 06, 2012... Vertex Pharmaceuticals (NASDAQ:VRTX) closed Friday's dramatic trading session at $36.78. In the past year, the stock has hit a 52-week low of $26.50......

http://www.marketintelligencecenter.com/analyfav/1332596

Weak Data Sends Stocks Lower with RadioShack (RSH) and Ford (F) on the Move

Tuesday, January 31, 2012... Closing out the day... Stocks finished lower today. Markets traded in a narrow range, after worse-than-expected U.S. housing and manufacturing data......

http://www.marketintelligencecenter.com/newsbites/1331568

Vertex Pharmaceuticals (VRTX) Up 6.4% After FDA Approves Cystic Fibrosis Drug

Tuesday, January 31, 2012... Vertex Pharmaceuticals (NASDAQ: VRTX) rose Tuesday after the FDA approved cystic fibrosis drug Kalydeco which treats a specific mutation that can......

http://www.marketintelligencecenter.com/newsbites/1331556

Vertex Pharmaceuticals (VRTX) Could Break Through $36.17 Resistance Level

Tuesday, January 31, 2012... Vertex Pharmaceuticals Inc (NASDAQ: VRTX) closed Monday's trading session at $34.74. In the past year, the stock has hit a 52-week low of $26.50 and......

http://www.marketintelligencecenter.com/analyfav/1331259


Hedged Trade Ideas For VRTX:



blog comments powered by Disqus


investorsobserver
OptionsXpress
Fidelity Investments
Brokers Xpress
money show 2011

FREE Daily Newsletter

 




Portions of this content may be copy written by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. SmartReadMX and other related related technologies used to produce content for this service are covered by US Patents numbers 7,865,496, 7,856,390, and 7,716,116.